跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSUVASTATINA/EZETIMIBA TEVA 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROSUVASTATINA/EZETIMIBA TEVA 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ROSUVASTATINA/EZETIMIBA TEVA 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 21, 2022
Approval ID
022a39b42c7c01e4
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
022a39b42c7c01e4
Drug Cima Aemps Name
ROSUVASTATINA/EZETIMIBA TEVA 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
86677
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-03-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
ROSUVASTATINA CALCICA
20,8 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 21, 2022
Approval ID
022a39b42c7c01e4
Type
Standard
Back to CIMA-AEMPS Approvals